Allergan to buy Pa.-based Vicept

Article

Allergan will pay as much as $275 million to acquire Vicept Therapeutics, the Orange County (Calif.) Business Journal reports.

Irvine, Calif. - Allergan, based here, will pay as much as $275 million to acquire Vicept Therapeutics, the Orange County (Calif.) Business Journal reports.

Allergan will pay $75 million for the company, based in Malvern, Pa., and up to $200 million in future milestone payments. Vicept’s V-101, a cream for treating redness associated with rosacea, is in mid-stage clinical trials. Vicept has two other products in the early stages of development.

An Allergan spokesman said the acquisition enhances the company’s dermatology research and development pipeline.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.